vaccine-coverage-and-hesitancy

npj Vaccines, Published online: 21 August 2026; doi:10.1038/s41541-026-01562-1 The effects of informational nudges on herpes zoster vaccination intentions in China: a survey experiment

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.

The positive Phase 3 result therefore provides clinical validation, at the level of RFS and DMFS, of a strategy combining individualized neoantigen-directed immunotherapy with established PD-1 blockade. It is important, however, not to extend the current findings beyond what the trial has demonstrated. INTerpath-001 establishes efficacy endpoints in resected high-risk cutaneous melanoma. It does …

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to help deliver next-generation mRNA therapeutics, including vaccines fighting against infectious disease, cancer and autoimmune conditions, faster and more efficiently than the industry standard.

The results, announced this week by Moderna and Merck, could pave the way for a new generation of treatments tailored to individual tumors

Measles is making a comeback around the world. In places with low vaccination rates, a few cases can quickly become an epidemic.

AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from weak ones. Surprisingly, even some healthy people responded poorly, while some immunosuppressed people mounted strong responses.

Evelyn Griffin is pushing for more emphasis on wellness and prevention. She has also aligned with the MAHA movement in fighting government mandates and questioning the safety of some vaccines.

Dana-Farber researchers found that inhibiting CARM1 may awaken dendritic cells, strengthen T-cell activity, and improve cancer vaccine effectiveness.

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to help deliver next-generation mRNA therapeutics, including vaccines to fight infectious diseases, cancer and autoimmune conditions, faster and more efficiently than the industry standard. In experiments with cells from people and mice, researchers at Johns Hopkins Medicine [&…

npj Vaccines, Published online: 19 August 2026; doi:10.1038/s41541-026-01556-z Paratuberculosis vaccination induces a phenotype consistent with trained immunity in bovine neutrophils

Nature Communications, Published online: 21 August 2026; doi:10.1038/s41467-026-76702-1 This study identifies four antigenic sites on CCHFV NP, showing that protection is independent of head or stalk location. It maps the highly conserved binding epitope of mAb-9D5 in the head domain, enabling broad-spectrum efficacy and opening the door for effective combination therapies.

Scientists have found that a little-known bacterial antibiotic is capable of disarming fungi responsible for...

The Epstein-Barr virus has taken a huge toll on global health. Understanding how it works could offer ways to combat multiple sclerosis, cancer and more.